Regional Insights
On the basis of region, the global transcatheter embolization and occlusion devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global transcatheter embolization and occlusion devices market and is expected to retain its dominance over the forecast period, owing to large population suffering from fibroid tumor, arteriovenous malformations (AVM), and other diseases. According to the American Association of Neurological Surgeons 2017, the prevalence of arteriovenous malfunctions (AVM) is estimated at 18 people per 100,000 population in the U.S. Moreover, the AVM is reported to be the second most identifiable cause for subarachnoid hemorrhage. Furthermore, leading players in the market are introducing novel products in the market and this is also expected to aid in growth of the market in the region. For instance, in September 2017, Medtronic Plc expanded its embolization product portfolio with the introduction of Concerto 3D detachable system in the U.S. and Europe that can be used in arterial and venous embolization.
Furthermore, Asia Pacific is expected to witness a significant growth in the market, which is attributed to increasing medical tourism in emerging economies such as Japan, India, and ASEAN countries that provides high quality medical services at low costs. According to International Medical Travel Journal, Indian hospitals served 460,000 international patients in 2015–2016 for various surgical procedures.
Transcatheter Embolization And Occlusion Devices Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients